These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 153883

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.
    Faguet GB.
    J Clin Invest; 1979 Jan; 63(1):67-74. PubMed ID: 153914
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Relationship between the capacity to be stimulated of lymphocyte subpopulations and the RAI staging in patients with chronic lymphocytic leukemia].
    Heilmann E, Venne U.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Jan; 106(3):365-74. PubMed ID: 89987
    [Abstract] [Full Text] [Related]

  • 7. [Stimulating effect of B-lymphocytes in mixed cultures on autologous T-lymphocytes in chronic lymphatic leukemia].
    Amadori G, Semenzato G, Tosato F, Gasparotto G.
    Boll Ist Sieroter Milan; 1976 Jan; 55(2):129-33. PubMed ID: 139155
    [Abstract] [Full Text] [Related]

  • 8. T-lymphocytes in B-cell chronic lymphocytic leukaemia.
    Foa R, Catovsky D, Lauria F, Zafar MN, Galton DA.
    Haematologica; 1981 Feb; 66(1):105-16. PubMed ID: 6785161
    [No Abstract] [Full Text] [Related]

  • 9. Alloantigen-induced suppressor- and memory cells in chronic lymphocytic leukemia.
    Kabelitz D, Fink U, Reichert A, Rastetter J.
    Immunobiology; 1982 May; 161(5):457-63. PubMed ID: 6212533
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS, Gol'dman EI.
    Vopr Onkol; 1978 May; 24(1):11-6. PubMed ID: 305684
    [Abstract] [Full Text] [Related]

  • 15. PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.
    Robert KH.
    Clin Exp Immunol; 1979 Sep; 37(3):517-22. PubMed ID: 315847
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. T-lymphocytes bearing Fc-receptors for IgG in B-cell chronic lymphocytic leukaemia.
    Matolcsy A, Magyarlaki T, Baliko Z, Tornoczky J.
    Haematologia (Budap); 1985 Sep; 18(3):185-91. PubMed ID: 2941348
    [Abstract] [Full Text] [Related]

  • 18. The effect of sera from chronic lymphocytic leukemia patients on normal mitogen-stimulated lymphocytes. A possible correlation with the patients' T and B lymphocytes.
    Komlos L, Halbrecht I, Shachor J, Djaldetti M.
    Exp Hematol; 1978 Aug; 6(7):595-600. PubMed ID: 308462
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.